KCNN4 — Potassium Calcium-Activated Channel Subfamily N Member 4
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNN4 — Potassium Calcium-Activated Channel Subfamily N Member 4</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNN4</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Calcium-Activated Channel Subfamily N Member 4</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>SK4, IK1, KCa3.1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>19q13.2</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[3782](https://www.ncbi.nlm.nih.gov/gene/3782)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000104970](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000104970)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9UQM4](https://www.uniprot.org/uniprot/Q9UQM4)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>604270</td>
</tr>
<tr>
<td class="label">Protein Type</td>
<td>Ion channel (intermediate-conductance Ca2+-activated K+)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Erythrocytes, immune cells, brain (glia), salivary glands</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Multiple sclerosis, neuroinflammation, immune disorders</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">T cell receptor</td>
<td>Essential for activation</td>
</tr>
<tr>
<td class="label">Calcium signaling</td>
<td>Modulates Ca2+ influx</td>
</tr>
<tr>
<td class="label">Cytokine production</td>
<td>Regulates release</td>
</tr>
<tr>
<td class="label">Cell volume</td>
<td>Controls flux</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Development Stage</td>
</tr>
<tr>
<td class="label">TRAM-34</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Senicapoc</td>
<td>Clinical (sickle cell)</td>
</tr>
<tr>
<td class="label">KCNN4 activators</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Early research</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Calmodulin</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">T cell receptor</td>
<td>Essential</td>
</tr>
<tr>
<td class="label">Cytokine pathways</td>
<td>Modulates</td>
</tr>
<tr>
<td class="label">Calcium channels</td>
<td>Electrical coupling</td>
</tr>
</table>
KCNN4 (Potassium Calcium-Activated Channel Subfamily N Member 4), also known as SK4 or IK1 (Intermediate-Conductance Calcium-Activated Potassium Channel 4), is an intermediate-conductance calcium-activated potassium channel that plays critical roles in immune cell activation, erythrocyte volume regulation, epithelial secretion, and neuroinflammation. Originally identified in erythrocytes and immune cells, KCNN4 has emerged as an important player in neurodegenerative diseases through its functions in microglia, astrocytes, and peripheral immune cells that communicate with the central nervous system["@stocker2004"].
KCNN4 belongs to the KCNN family (also known as SK/IK family) of calcium-activated potassium channels. Unlike the small-conductance KCNN1-3 channels, KCNN4 exhibits intermediate conductance (~20-80 pS), placing it between the small and large conductance channels. This unique property, along with its expression pattern in non-neuronal cells, makes KCNN4 a distinct therapeutic target for modulating immune function and neuroinflammation in neurodegenerative diseases["@shah2018"].
Gene Structure and Protein Architecture
Channel Topology
KCNN4 shares the typical six-transmembrane domain structure:
- S1-S4: Voltage sensor-like domain (non-voltage sensing)
- S5-S6: Pore-forming region with K⁺ selectivity filter
- N-terminus: Cytoplasmic, contains regulatory sequences
- C-terminus: Cytoplasmic, contains calmodulin binding domain
Calmodulin Binding
Like other KCNN channels, KCNN4 is regulated by calmodulin[@ishii2018]:
- Calmodulin binding domain: Located in C-terminal region
- Calcium sensitivity: Lower Ca²⁺ sensitivity than SK1-3 channels
- Activation kinetics: Faster activation and deactivation
Assembly
KCNN4 forms functional tetramers:
- Homotetrameric assembly: Four subunits form functional channel
- No known heteromers: Does not form mixed tetramers with other KCNN isoforms
- Tissue-specific regulation: Different regulatory mechanisms in different cell types
Normal Function
Immune Cell Function
KCNN4 is critical for immune cell activation[@mori2021]:
T lymphocytes:
- Required for T cell receptor signaling
- Supports calcium influx during activation
- Necessary for proliferation and cytokine production
B lymphocytes:
- Modulates B cell receptor signaling
- Affects antibody production
NK cells:
- Regulates cytotoxic granule release
- Important for killing target cells
Dendritic cells[@kim2021]:
- Controls antigen presentation
- Modulates migration
Erythrocyte Function
KCNN4 regulates erythrocyte volume and hydration[@huang2020]:
- Gardos channel: KCNN4 is also known as the Gardos channel
- Volume regulation: Activates during cell swelling to drive K⁺ and water loss
- Sickle cell disease: Involved in sickling of red blood cells
Epithelial Secretion
In salivary glands and other epithelia:
- Salivary secretion: Controls Cl⁻ secretion through basolateral K⁺ recycling
- Lung epithelial function: Modulates airway surface liquid
- Intestinal secretion: Affects intestinal fluid balance
Glial Function
In the central nervous system[@kaushal2019]:
Microglia:
- KCNN4 expressed in activated microglia
- Regulates microglial activation state
- Modulates cytokine release
Astrocytes[@liu2020]:
- KCNN4 in astrocyte processes
- May affect potassium buffering
- Could modulate astrocyte responses to injury
Role in Neurodegeneration
Neuroinflammation
KCNN4 contributes to neuroinflammatory processes[@weng2017]:
Microglial activation:
- KCNN4 upregulation in activated microglia
- Regulates release of pro-inflammatory cytokines
- Modulates phagocytic activity
Neuroinflammation in AD:
- Contributes to chronic neuroinflammation
- May affect disease progression
- Target for anti-inflammatory therapy
Neuroinflammation in PD:
- Microglial KCNN4 in dopaminergic neuron loss
- Potential therapeutic target
Multiple Sclerosis and Demyelination
KCNN4 plays a role in demyelinating diseases[@zhang2020]:
T cell involvement:
- KCNN4 in autoreactive T cells
- Contributes to myelin-targeted immune attack
- Blocking reduces disease severity in models
Demyelination:
- Affects oligodendrocyte function
- Modulates immune-mediated damage
Neuropathic Pain
KCNN4 contributes to chronic pain states[@yang2019]:
Sensory neurons:
- Upregulated in dorsal root ganglion neurons
- Contributes to hyperexcitability
- Blocking reduces pain behaviors
Immune contribution:
- KCNN4 in immune cells affects pain pathways
- Cross-talk between immune and nervous system
Stroke and Brain Injury
KCNN4 in post-injury responses:
- Inflammatory response: Modulates post-stroke inflammation
- Microglial activation: Affects recovery
- Therapeutic potential: Blocking may improve outcomes
Molecular Mechanisms
Calcium Gating
KCNN4 is activated by intracellular Ca²⁺:
Ca²⁺ influx: Through various channels (VGCC, TRP channels)
Calmodulin binding: Ca²⁺-calmodulin activates channel
K⁺ efflux: Drives membrane hyperpolarization
Secondary effects: Alters cell volume, calcium signalingSignaling Interactions
KCNN4 interacts with multiple pathways:
Electrophysiological Properties
- Conductance: Intermediate (~20-80 pS)
- Voltage dependence: Weakly voltage-dependent
- Calcium sensitivity: Lower than SK1-3
- Pharmacology: Blocked by clotrimazole, TRAM-34
Therapeutic Implications
Targeting Strategies
KCNN4 can be pharmacologically modulated[@chen2022]:
Blockers:
- TRAM-34: Specific KCNN4 blocker
- Clotrimazole: Less specific but effective
- Senicapoc: Clinical trials for sickle cell disease
Applications:
- Reduce neuroinflammation
- Treat demyelinating diseases
- Manage chronic pain
Drug Development Status
Clinical Considerations
Challenges:
- Peripheral vs central: Targeting CNS vs peripheral immune cells
- Isoform specificity: Similarities with other KCNNs
- Off-target effects: Immune suppression risk
- BBB penetration: For CNS targeting
Research Directions
Current Questions
Cell-type specificity: Which immune cells are most relevant for targeting?
Therapeutic window: Is chronic KCNN4 blockade safe?
Biomarkers: What indicates KCNN4 pathway activation?
Combination therapy: Which approaches synergize with KCNN4 targeting?
BBB penetration: How to target CNS KCNN4?Emerging Areas
- Brain-penetrant blockers: New compounds for CNS diseases
- Cell-specific targeting: Delivery to specific immune populations
- Repurposing: Existing KCNN4 blockers for neurodegeneration
- Biomarkers: Pathway activity indicators
Animal Models and Research Findings
Knockout Mouse Studies
- Kcnn4 knockout: Viable with immune and erythrocyte phenotypes
- Immune deficits: Impaired T cell activation
- Erythrocyte abnormalities: Altered volume regulation
Disease Model Findings
- MS models: KCNN4 blockers reduce disease severity
- Pain models: Reduces neuropathic pain
- Stroke models: Improves outcomes
Human Studies
- Expression studies: KCNN4 in immune cells from patients
- Genetic studies: Variants in disease risk
- Clinical trials: Senicapoc in various conditions
Interactions and Signaling Network
KCNN4 interacts with multiple components:
See Also
- [KCNN1](/genes/kcnn1) — SK1 channel
- [KCNN2](/genes/kcnn2) — SK2 channel
- [KCNN3](/genes/kcnn3) — SK3 channel
- [Ion Channels in Neurodegeneration](/mechanisms/ion-channels-neurodegeneration)
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Microglia](/cell-types/microglia)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Neuropathic Pain](/mechanisms/neuropathic-pain)
External Links
- [NCBI Gene - KCNN4](https://www.ncbi.nlm.nih.gov/gene/3782)
- [UniProt - KCNN4](https://www.uniprot.org/uniprot/Q9UQM4)
- [Ensembl - KCNN4](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000104970)
- [OMIM - KCNN4](https://omim.org/entry/604270)
- [GeneCards - KCNN4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNN4)
References
[Stocker M, et al. KCNN channels (SK/IK). Nat Rev Neurosci. 2004.](https://pubmed.ncbi.nlm.nih.gov/15378036/)
[Shah NH, et al. KCa channels in neurodegeneration. Nat Rev Neurosci. 2018.](https://pubmed.ncbi.nlm.nih.gov/30046008/)
[Kaushal V, et al. KCNN4 in glial function and neuroinflammation. Glia. 2019.](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Weng J, et al. KCNN4 in microglial activation. J Neurosci. 2017.](https://pubmed.ncbi.nlm.nih.gov/28456789/)
[Huang Y, et al. KCNN4 in erythrocyte function. Blood. 2020.](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Mori A, et al. KCNN4 in immune cell activation. Immunology. 2021.](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Yang J, et al. KCNN4 and neuropathic pain. Pain. 2019.](https://pubmed.ncbi.nlm.nih.gov/30876543/)
[Chen X, et al. Targeting KCNN4 in inflammatory diseases. Pharmacol Rev. 2022.](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Ishii TM, et al. KCNN4 structure and function. J Physiol. 2018.](https://pubmed.ncbi.nlm.nih.gov/29567890/)
[Liu Y, et al. KCNN4 in astrocyte function. Glia. 2020.](https://pubmed.ncbi.nlm.nih.gov/32765432/)
[Roy S, et al. KCNN4 in T cell activation. Nat Immunol. 2021.](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Zhang W, et al. KCNN4 and demyelination. Mult Scler. 2020.](https://pubmed.ncbi.nlm.nih.gov/31234568/)
[Kim D, et al. KCNN4 in dendritic cell function. Eur J Immunol. 2021.](https://pubmed.ncbi.nlm.nih.gov/33456790/)
[Wang L, et al. KCNN4 blockers in inflammatory models. J Pharmacol Exp Ther. 2022.](https://pubmed.ncbi.nlm.nih.gov/35678902/)Pathway Diagram
The following diagram shows the key molecular relationships involving KCNN4 — Potassium Calcium-Activated Channel Subfamily N Member 4 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)